Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease
Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease